Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Stem cells

The dark side of induced pluripotency

Induced pluripotent stem cells have great therapeutic potential. But genomic and epigenomic analyses of these cells generated using current technology reveal abnormalities that may affect their safe use. See Articles p.58, p.63 & p.68

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

References

  1. Hussein, S. M. et al. Nature 471, 58–62 (2011).

    ADS  CAS  Article  Google Scholar 

  2. Gore, A. et al. Nature 471, 63–67 (2011).

    ADS  CAS  Article  Google Scholar 

  3. Lister, R. et al. Nature 471, 68–73 (2011).

    ADS  CAS  Article  Google Scholar 

  4. Mayshar, Y. et al. Cell Stem Cell 7, 521–531 (2010).

    CAS  Article  Google Scholar 

  5. Laurent, L. C. et al. Cell Stem Cell 8, 106–118 (2011).

    CAS  Article  Google Scholar 

  6. Baker, D. E. C. et al. Nature Biotechnol. 25, 207–215 (2007).

    CAS  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Martin F. Pera.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Pera, M. The dark side of induced pluripotency. Nature 471, 46–47 (2011). https://doi.org/10.1038/471046a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/471046a

This article is cited by

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer